Mcintyre Freedman & Flynn Investment Advisers Inc Abbott Laboratories Transaction History
Mcintyre Freedman & Flynn Investment Advisers Inc
- $138 Billion
- Q1 2024
A detailed history of Mcintyre Freedman & Flynn Investment Advisers Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mcintyre Freedman & Flynn Investment Advisers Inc holds 2,490 shares of ABT stock, worth $259,009. This represents 0.21% of its overall portfolio holdings.
Number of Shares
2,490
Previous 2,490
-0.0%
Holding current value
$259,009
Previous $274 Million
3.26%
% of portfolio
0.21%
Previous 0.22%
Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,130Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$17.2 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.8 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.74 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.77 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.3 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $182B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...